Daliresp® Roflumilast 500 mcg Tablets for COPD Treatment - 90 Count Bottle

USAMP#38224325SKU: 00310009590Daliresp®
rxLicense

License Required

wishlistAltwishlistAlt
productImage

Product Spotlight

  • Contains 500 mcg of Roflumilast, a potent Phosphodiesterase Type 4 Inhibitor.
  • Manufactured by AstraZeneca Pharmaceuticals, ensuring high-quality medication.
  • Prescription-only medication designed for the management of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD).
  • Comes in a bottle of 90 tablets, providing a comprehensive treatment course.
  • Formulated without latex, making it suitable for individuals with latex allergies.
  • Specifically targets inflammation and bronchoconstriction in COPD patients, improving lung function and reducing exacerbations.